Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Originally published in Science Express on 9 May 2002
Science 7 June 2002:
Vol. 296. no. 5574, pp. 1886 - 1889
DOI: 10.1126/science.1073440

Reports

Structure of an HIF-1alpha -pVHL Complex: Hydroxyproline Recognition in Signaling

Jung-Hyun Min,1 Haifeng Yang,2 Mircea Ivan,2 Frank Gertler,4 William G. Kaelin Jr.,23 Nikola P. Pavletich1*

The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1alpha peptide-pVHL-ElonginB-ElonginC complex shows that HIF-1alpha binds to pVHL in an extended beta  strand-like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the beta  sheet-like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.

1 Cellular Biochemistry and Biophysics Program and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
2 Dana-Farber Cancer Institute and
3 Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA.
4 Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
*   To whom correspondence should be addressed. E-mail: nikola{at}xray2.mskcc.org.


Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Two Distinct Roles for EGL-9 in the Regulation of HIF-1-Mediated Gene Expression in Caenorhabditis elegans.
Z. Shao, Y. Zhang, and J. A. Powell-Coffman (2009)
Genetics 183, 821-829
   Abstract »    Full Text »    PDF »
Kruppel-like Factor 2 Inhibits Hypoxia-inducible Factor 1{alpha} Expression and Function in the Endothelium.
D. Kawanami, G. H. Mahabeleshwar, Z. Lin, G. B. Atkins, A. Hamik, S. M. Haldar, K. Maemura, J. C. LaManna, and M. K. Jain (2009)
J. Biol. Chem. 284, 20522-20530
   Abstract »    Full Text »    PDF »
The F-box Protein {beta}-TrCp1/Fbw1a Interacts with p300 to Enhance {beta}-Catenin Transcriptional Activity.
E. A. Kimbrel and A. L. Kung (2009)
J. Biol. Chem. 284, 13033-13044
   Abstract »    Full Text »    PDF »
VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL.
K. Knauth, E. Cartwright, S. Freund, M. Bycroft, and A. Buchberger (2009)
J. Biol. Chem. 284, 10514-10522
   Abstract »    Full Text »    PDF »
Erythrocytosis-associated HIF-2{alpha} Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline.
P. W. Furlow, M. J. Percy, S. Sutherland, C. Bierl, M. F. McMullin, S. R. Master, T. R. J. Lappin, and F. S. Lee (2009)
J. Biol. Chem. 284, 9050-9058
   Abstract »    Full Text »    PDF »
The Ubiquitin Ligase Siah2 and the Hypoxia Response.
K. Nakayama, J. Qi, and Z. Ronai (2009)
Mol. Cancer Res. 7, 443-451
   Abstract »    Full Text »    PDF »
U19/Eaf2 Binds to and Stabilizes von Hippel-Lindau Protein.
W. Xiao, J. Ai, G. Habermacher, O. Volpert, X. Yang, A.-y. Zhang, J. Hahn, X. Cai, and Z. Wang (2009)
Cancer Res. 69, 2599-2606
   Abstract »    Full Text »    PDF »
The Structure of YqeH: AN AtNOS1/AtNOA1 ORTHOLOG THAT COUPLES GTP HYDROLYSIS TO MOLECULAR RECOGNITION.
J. Sudhamsu, G. I. Lee, D. F. Klessig, and B. R. Crane (2008)
J. Biol. Chem. 283, 32968-32976
   Abstract »    Full Text »    PDF »
Transcriptional Regulation of Serine/Threonine Kinase-15 (STK15) Expression by Hypoxia and HIF-1.
A. Klein, D. Flugel, and T. Kietzmann (2008)
Mol. Biol. Cell 19, 3667-3675
   Abstract »    Full Text »    PDF »
Hypoxia and the Hypoxia-Inducible Factors in the Skeleton.
E. Schipani and T. L. Clemens (2008)
IBMS BoneKEy 5, 275-284
   Abstract »    Full Text »    PDF »
Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis.
M. J. Percy, P. A. Beer, G. Campbell, A. W. Dekker, A. R. Green, D. Oscier, M. G. Rainey, R. van Wijk, M. Wood, T. R. J. Lappin, et al. (2008)
Blood 111, 5400-5402
   Abstract »    Full Text »    PDF »
Allosteric effects in the marginally stable von Hippel-Lindau tumor suppressor protein and allostery-based rescue mutant design.
J. Liu and R. Nussinov (2008)
PNAS 105, 901-906
   Abstract »    Full Text »    PDF »
A yeast two-hybrid system reconstituting substrate recognition of the von Hippel-Lindau tumor suppressor protein.
C. Bex, K. Knauth, S. Dambacher, and A. Buchberger (2007)
Nucleic Acids Res. 35, e142
   Abstract »    Full Text »    PDF »
Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor.
J. Koditz, J. Nesper, M. Wottawa, D. P. Stiehl, G. Camenisch, C. Franke, J. Myllyharju, R. H. Wenger, and D. M. Katschinski (2007)
Blood 110, 3610-3617
   Abstract »    Full Text »    PDF »
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1.
J.-w. Kim, P. Gao, Y.-C. Liu, G. L. Semenza, and C. V. Dang (2007)
Mol. Cell. Biol. 27, 7381-7393
   Abstract »    Full Text »    PDF »
Internal En Bloc Resection and Genetic Analysis of Retinal Capillary Hemangioblastoma.
T. Schlesinger, B. Appukuttan, T. Hwang, L.-o. Atchaneeyakasul, C.-C. Chan, Z. Zhuang, J. T. Stout, and D. J. Wilson (2007)
Arch Ophthalmol 125, 1189-1193
   Abstract »    Full Text »    PDF »
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations.
L. Li, L. Zhang, X. Zhang, Q. Yan, Y. A. Minamishima, A. F. Olumi, M. Mao, S. Bartz, and W. G. Kaelin Jr. (2007)
Mol. Cell. Biol. 27, 5381-5392
   Abstract »    Full Text »    PDF »
Hypoxia-Inducible Factor-1 Facilitates Cervical Cancer Progression in Human Papillomavirus Type 16 Transgenic Mice.
Z. H. Lu, J. D. Wright, B. Belt, R. D. Cardiff, and J. M. Arbeit (2007)
Am. J. Pathol. 171, 667-681
   Abstract »    Full Text »    PDF »
Identification of Protein-Protein Interactions with Glutathione-S-Transferase (GST) Fusion Proteins.
M. B. Einarson, E. N. Pugacheva, and J. R. Orlinick (2007)
CSH Protocols 2007, pdb.top11
   Abstract »    Full Text »
Substrate-mediated Regulation of Cullin Neddylation.
E.-H. Chew and T. Hagen (2007)
J. Biol. Chem. 282, 17032-17040
   Abstract »    Full Text »    PDF »
Hif-1{alpha} regulates differentiation of limb bud mesenchyme and joint development.
S. Provot, D. Zinyk, Y. Gunes, R. Kathri, Q. Le, H. M. Kronenberg, R. S. Johnson, M. T. Longaker, A. J. Giaccia, and E. Schipani (2007)
J. Cell Biol. 177, 451-464
   Abstract »    Full Text »    PDF »
Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor.
A. Grosfeld, I. P. Stolze, M. E. Cockman, C. W. Pugh, M. Edelmann, B. Kessler, A. N. Bullock, P. J. Ratcliffe, and N. Masson (2007)
J. Biol. Chem. 282, 13264-13269
   Abstract »    Full Text »    PDF »
Suppression of the Hypoxia-Inducible Factor-1 Response in Cervical Carcinoma Xenografts by Proteasome Inhibitors.
D. C. Birle and D. W. Hedley (2007)
Cancer Res. 67, 1735-1743
   Abstract »    Full Text »    PDF »
Multiple Factors Affecting Cellular Redox Status and Energy Metabolism Modulate Hypoxia-Inducible Factor Prolyl Hydroxylase Activity In Vivo and In Vitro.
Y. Pan, K. D. Mansfield, C. C. Bertozzi, V. Rudenko, D. A. Chan, A. J. Giaccia, and M. C. Simon (2007)
Mol. Cell. Biol. 27, 912-925
   Abstract »    Full Text »    PDF »
Hypoxia-Inducible Factor-1 (HIF-1).
Q. Ke and M. Costa (2006)
Mol. Pharmacol. 70, 1469-1480
   Abstract »    Full Text »    PDF »
Peroxisomal Localization of Hypoxia-Inducible Factors and Hypoxia-Inducible Factor Regulatory Hydroxylases in Primary Rat Hepatocytes Exposed to Hypoxia-Reoxygenation.
Z. Khan, G. K. Michalopoulos, and D. B. Stolz (2006)
Am. J. Pathol. 169, 1251-1269
   Abstract »    Full Text »    PDF »
The Length of Peptide Substrates Has a Marked Effect on Hydroxylation by the Hypoxia-inducible Factor Prolyl 4-Hydroxylases.
P. Koivunen, M. Hirsila, K. I. Kivirikko, and J. Myllyharju (2006)
J. Biol. Chem. 281, 28712-28720
   Abstract »    Full Text »    PDF »
Priming-Dependent Phosphorylation and Regulation of the Tumor Suppressor pVHL by Glycogen Synthase Kinase 3.
A. Hergovich, J. Lisztwan, C. R. Thoma, C. Wirbelauer, R. E. Barry, and W. Krek (2006)
Mol. Cell. Biol. 26, 5784-5796
   Abstract »    Full Text »    PDF »
Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
M. A. McDonough, V. Li, E. Flashman, R. Chowdhury, C. Mohr, B. M. R. Lienard, J. Zondlo, N. J. Oldham, I. J. Clifton, J. Lewis, et al. (2006)
PNAS 103, 9814-9819
   Abstract »    Full Text »    PDF »
Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-{alpha}.
D. M. Fath, X. Kong, D. Liang, Z. Lin, A. Chou, Y. Jiang, J. Fang, J. Caro, and N. Sang (2006)
J. Biol. Chem. 281, 13612-13619
   Abstract »    Full Text »    PDF »
Solution Structure of the Human Ubiquitin-specific Protease 15 DUSP Domain.
R. N. de Jong, E. AB, T. Diercks, V. Truffault, M. Daniels, R. Kaptein, and G. E. Folkers (2006)
J. Biol. Chem. 281, 5026-5031
   Abstract »    Full Text »    PDF »
Inhibition of the Catalytic Activity of Hypoxia-Inducible Factor-1{alpha}-Prolyl-Hydroxylase 2 by a MYND-Type Zinc Finger.
K.-O. Choi, T. Lee, N. Lee, J.-H. Kim, E. G. Yang, J. M. Yoon, J. H. Kim, T. G. Lee, and H. Park (2005)
Mol. Pharmacol. 68, 1803-1809
   Abstract »    Full Text »    PDF »
Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes.
S. J. Marx and W. F. Simonds (2005)
Endocr. Rev. 26, 615-661
   Abstract »    Full Text »    PDF »
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma.
R. R. Raval, K. W. Lau, M. G. B. Tran, H. M. Sowter, S. J. Mandriota, J.-L. Li, C. W. Pugh, P. H. Maxwell, A. L. Harris, and P. J. Ratcliffe (2005)
Mol. Cell. Biol. 25, 5675-5686
   Abstract »    Full Text »    PDF »
The Skp1 Prolyl Hydroxylase from Dictyostelium Is Related to the Hypoxia-inducible Factor-{alpha} Class of Animal Prolyl 4-Hydroxylases.
H. van der Wel, A. Ercan, and C. M. West (2005)
J. Biol. Chem. 280, 14645-14655
   Abstract »    Full Text »    PDF »
From the Cover: Osteocalcin protein sequences of Neanderthals and modern primates.
C. M. Nielsen-Marsh, M. P. Richards, P. V. Hauschka, J. E. Thomas-Oates, E. Trinkaus, P. B. Pettitt, I. Karavanic, H. Poinar, and M. J. Collins (2005)
PNAS 102, 4409-4413
   Abstract »    Full Text »    PDF »
Inactivation of VHL by Tumorigenic Mutations That Disrupt Dynamic Coupling of the pVHL{middle dot}Hypoxia-inducible Transcription Factor-1{alpha} Complex.
F. Miller, A. Kentsis, R. Osman, and Z.-Q. Pan (2005)
J. Biol. Chem. 280, 7985-7996
   Abstract »    Full Text »    PDF »
The von Hippel-Lindau Tumor Suppressor Protein: Roles in Cancer and Oxygen Sensing.
W.G. KAELIN JR. (2005)
Cold Spring Harb Symp Quant Biol 70, 159-166
   Abstract »    PDF »
Many Amino Acid Substitutions in a Hypoxia-inducible Transcription Factor (HIF)-1{alpha}-like Peptide Cause Only Minor Changes in Its Hydroxylation by the HIF Prolyl 4-Hydroxylases: SUBSTITUTION OF 3,4-DEHYDROPROLINE OR AZETIDINE-2-CARBOXYLIC ACID FOR THE PROLINE LEADS TO A HIGH RATE OF UNCOUPLED 2-OXOGLUTARATE DECARBOXYLATION.
D. Li, M. Hirsila, P. Koivunen, M. C. Brenner, L. Xu, C. Yang, K. I. Kivirikko, and J. Myllyharju (2004)
J. Biol. Chem. 279, 55051-55059
   Abstract »    Full Text »    PDF »
Role of VHL Gene Mutation in Human Cancer.
W. Y. Kim and W. G. Kaelin (2004)
J. Clin. Oncol. 22, 4991-5004
   Abstract »    Full Text »    PDF »
Solution Structure of a Ubiquitin-like Domain from Tubulin-binding Cofactor B.
B. L. Lytle, F. C. Peterson, S.-H. Qiu, M. Luo, Q. Zhao, J. L. Markley, and B. F. Volkman (2004)
J. Biol. Chem. 279, 46787-46793
   Abstract »    Full Text »    PDF »
Ubiquitin-protein ligases.
P. A. Robinson and H. C. Ardley (2004)
J. Cell Sci. 117, 5191-5194
   Full Text »    PDF »
Identification of Elongin C and Skp1 Sequences That Determine Cullin Selection.
Q. Yan, T. Kamura, Y. Cai, J. Jin, M. Ivan, A. Mushegian, R. C. Conaway, and J. W. Conaway (2004)
J. Biol. Chem. 279, 43019-43026
   Abstract »    Full Text »    PDF »
Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury.
A. S. Pachori, L. G. Melo, M. L. Hart, N. Noiseux, L. Zhang, F. Morello, S. D. Solomon, G. L. Stahl, R. E. Pratt, and V. J. Dzau (2004)
PNAS 101, 12282-12287
   Abstract »    Full Text »    PDF »
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level.
G. L. Semenza (2004)
Physiology 19, 176-182
   Abstract »    Full Text »    PDF »
Inhibition of Ocular Angiogenesis by an Adenovirus Carrying the Human von Hippel-Lindau Tumor-Suppressor Gene In Vivo.
H. Akiyama, T. Tanaka, H. Itakura, H. Kanai, T. Maeno, H. Doi, M. Yamazaki, K. Takahashi, Y. Kimura, S. Kishi, et al. (2004)
Invest. Ophthalmol. Vis. Sci. 45, 1289-1296
   Abstract »    Full Text »    PDF »
The von Hippel-Lindau Tumor Suppressor Protein Is a Molten Globule under Native Conditions: IMPLICATIONS FOR ITS PHYSIOLOGICAL ACTIVITIES.
H. Sutovsky and E. Gazit (2004)
J. Biol. Chem. 279, 17190-17196
   Abstract »    Full Text »    PDF »
Molecular Cloning and Characterization of the von Hippel-Lindau-Like Protein.
H. Qi, M. L. Gervais, W. Li, J. A. DeCaprio, J. R.G. Challis, and M. Ohh (2004)
Mol. Cancer Res. 2, 43-52
   Abstract »    Full Text »    PDF »
Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible factor.
P. J. A. Erbel, P. B. Card, O. Karakuzu, R. K. Bruick, and K. H. Gardner (2003)
PNAS 100, 15504-15509
   Abstract »    Full Text »    PDF »
Identification and Characterization of a Third Human, Rat, and Mouse Collagen Prolyl 4-Hydroxylase Isoenzyme.
L. Kukkola, R. Hieta, K. I. Kivirikko, and J. Myllyharju (2003)
J. Biol. Chem. 278, 47685-47693
   Abstract »    Full Text »    PDF »
Regulation of the Chemokine Receptor CXCR4 by Hypoxia.
T. Schioppa, B. Uranchimeg, A. Saccani, S. K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, et al. (2003)
J. Exp. Med. 198, 1391-1402
   Abstract »    Full Text »    PDF »
Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor.
R. K. Bruick (2003)
Genes & Dev. 17, 2614-2623
   Full Text »    PDF »
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing.
W. G. Kaelin Jr. (2003)
J. Am. Soc. Nephrol. 14, 2703-2711
   Abstract »    Full Text »    PDF »
HIF-1: An Oxygen Response System with Special Relevance to the Kidney.
P. Maxwell (2003)
J. Am. Soc. Nephrol. 14, 2712-2722
   Full Text »    PDF »
Oxygen and Iron Regulation of Iron Regulatory Protein 2.
E. S. Hanson, M. L. Rawlins, and E. A. Leibold (2003)
J. Biol. Chem. 278, 40337-40342
   Abstract »    Full Text »    PDF »
Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor.
M. Hirsila, P. Koivunen, V. Gunzler, K. I. Kivirikko, and J. Myllyharju (2003)
J. Biol. Chem. 278, 30772-30780
   Abstract »    Full Text »    PDF »
HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels.
N. Masson and P. J. Ratcliffe (2003)
J. Cell Sci. 116, 3041-3049
   Abstract »    Full Text »    PDF »
Nitric Oxide Impairs Normoxic Degradation of HIF-1{alpha} by Inhibition of Prolyl Hydroxylases.
E. Metzen, J. Zhou, W. Jelkmann, J. Fandrey, and B. Brune (2003)
Mol. Biol. Cell 14, 3470-3481
   Abstract »    Full Text »    PDF »
Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells.
Z.-Z. Yang, A. Y. Zhang, F.-X. Yi, P.-L. Li, and A.-P. Zou (2003)
Am J Physiol Renal Physiol 284, F1207-F1215
   Abstract »    Full Text »    PDF »
Hypoxia-inducible Factor and Its Biomedical Relevance.
L. E. Huang and H. F. Bunn (2003)
J. Biol. Chem. 278, 19575-19578
   Full Text »    PDF »
Assembly of Cell Regulatory Systems Through Protein Interaction Domains.
T. Pawson and P. Nash (2003)
Science 300, 445-452
   Abstract »    Full Text »    PDF »
MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300.
N. Sang, D. P. Stiehl, J. Bohensky, I. Leshchinsky, V. Srinivas, and J. Caro (2003)
J. Biol. Chem. 278, 14013-14019
   Abstract »    Full Text »    PDF »
Intracellular localisation of human HIF-1{alpha} hydroxylases: implications for oxygen sensing.
E. Metzen, U. Berchner-Pfannschmidt, P. Stengel, J. H. Marxsen, I. Stolze, M. Klinger, W. Q. Huang, C. Wotzlaw, T. Hellwig-Burgel, W. Jelkmann, et al. (2003)
J. Cell Sci. 116, 1319-1326
   Abstract »    Full Text »    PDF »
von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination.
A. V. Kuznetsova, J. Meller, P. O. Schnell, J. A. Nash, M. L. Ignacak, Y. Sanchez, J. W. Conaway, R. C. Conaway, and M. F. Czyzyk-Krzeska (2003)
PNAS 100, 2706-2711
   Abstract »    Full Text »    PDF »
Identification of Residues Critical for Regulation of Protein Stability and the Transactivation Function of the Hypoxia-inducible Factor-1alpha by the von Hippel-Lindau Tumor Suppressor Gene Product.
T. Pereira, X. Zheng, J. L. Ruas, K. Tanimoto, and L. Poellinger (2003)
J. Biol. Chem. 278, 6816-6823
   Abstract »    Full Text »    PDF »
Mutations in the VHL gene in sporadic apparently congenital polycythemia.
Y. D. Pastore, J. Jelinek, S. Ang, Y. Guan, E. Liu, K. Jedlickova, L. Krishnamurti, and J. T. Prchal (2003)
Blood 101, 1591-1595
   Abstract »    Full Text »    PDF »
Structure of Factor-inhibiting Hypoxia-inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1alpha.
J. M. Elkins, K. S. Hewitson, L. A. McNeill, J. F. Seibel, I. Schlemminger, C. W. Pugh, P. J. Ratcliffe, and C. J. Schofield (2003)
J. Biol. Chem. 278, 1802-1806
   Abstract »    Full Text »    PDF »
Leu-574 of HIF-1alpha Is Essential for the von Hippel-Lindau (VHL)-mediated Degradation Pathway.
L. E. Huang, E. A. Pete, M. Schau, J. Milligan, and J. Gu (2002)
J. Biol. Chem. 277, 41750-41755
   Abstract »    Full Text »    PDF »
Sequence Determinants in Hypoxia-inducible Factor-1alpha for Hydroxylation by the Prolyl Hydroxylases PHD1, PHD2, and PHD3.
J. Huang, Q. Zhao, S. M. Mooney, and F. S. Lee (2002)
J. Biol. Chem. 277, 39792-39800
   Abstract »    Full Text »    PDF »
Physiology meets biophysics: Visualizing the interaction of hypoxia-inducible factor 1alpha with p300 and CBP.
G. L. Semenza (2002)
PNAS 99, 11570-11572
   Full Text »    PDF »
Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis.
C. Willam, N. Masson, Y.-M. Tian, S. A. Mahmood, M. I. Wilson, R. Bicknell, K.-U. Eckardt, P. H. Maxwell, P. J. Ratcliffe, and C. W. Pugh (2002)
PNAS 99, 10423-10428
   Abstract »    Full Text »    PDF »
Regulation of Gene Expression by the Hypoxia-Inducible Factors.
A. O. Fedele, M. L. Whitelaw, and D. J. Peet (2002)
Mol. Interv. 2, 229-243
   Abstract »    Full Text »    PDF »
Quiescent Hypervascularity Mediated by Gain of HIF-1{alpha} Function.
J.M. ARBEIT (2002)
Cold Spring Harb Symp Quant Biol 67, 133-142
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)